WL-AAB-Z-W-401
- Manufacturer
- Nanophase Technologies Corporation
- Effective date
- 2023-01-10
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:41:02
Label at a glance#
ProductWL-AAB-Z-W-401
Active ingredientZINC OXIDE
Label structure1 sections
Label contents#
Full prescribing information#
Products#
Every source-derived product name is available through these pages.
- WL-AAB-Z-W-401
- Zinc Oxide
- PALMITOYL TETRAPEPTIDE-7
- TRILAURETH-4 PHOSPHATE
- BUTYLOCTYL SALICYLATE
- OCTYLDODECYL NEOPENTANOATE
- ISODODECANE
- .ALPHA.-BISABOLOL, (+)-
- BUTYLENE GLYCOL
- POLYSORBATE 20
- SODIUM HYDROXIDE
- WATER
- NIACINAMIDE
- ETHYLHEXYLGLYCERIN
- HEXYLENE GLYCOL
- GLYCERIN
- DIMETHICONOL/PROPYLSILSESQUIOXANE/SILICATE CROSSPOLYMER (450000000 MW)
- PROPANEDIOL
- TETRASODIUM GLUTAMATE DIACETATE
- CARRAGEENAN
- SODIUM CHLORIDE
- PHENOXYETHANOL
- PALMITOYL TRIPEPTIDE-1
- .BETA.-TOCOPHEROL
- POLYMETHYLSILSESQUIOXANE (4.5 MICRONS)
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 63931-4325 | 63931-4325-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f1ed1d9c-8d87-a288-e053-2995a90af3fa | 8f62fb1b-2092-36d2-e053-2a95a90abfc6 | 2023-01-10 | f1ed1d9c-8d87-a288-e053-2995a90af3fa 8f62fb1b-2092-36d2-e053-2a95a90abfc6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
